Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kotelevtsev

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cardiovascular Research|June 14, 2002
Application of gene expression profiling to cardiovascular diseaseP A Henriksen, Y Kotelevtsev
Journal of Cardiovascular Pharmacology|November 15, 2000
A transgenic strategy for analysis of the function of the endothelin-B-receptorA Bagnall, D Webb, Y Kotelevtsev
Molecular and Cellular Endocrinology|February 13, 2001
Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genesM C Holmes, Y Kotelevtsev, J J Mullins, et al.
Endocrinology|January 6, 2001
Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient miceH J Harris, Y Kotelevtsev, J J Mullins, et al.
The Journal of Biological Chemistry|September 8, 1995
Human mineralocorticoid receptor genomic structure and identification of expressed isoformsM C Zennaro, M C Keightley, Y Kotelevtsev, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairmentsJ L Yau, J Noble, C J Kenyon, et al.
The Journal of Clinical Investigation|March 13, 1999
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2Y Kotelevtsev, R W Brown, S Fleming, et al.
Kidney International|February 1, 1995
A genetic model of malignant phase hypertension in ratsC E Whitworth, S Fleming, Y Kotelevtsev, et al.
Kidney International|August 5, 1999
Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 ratsS Kantachuvesiri, C S Haley, S Fleming, et al.
The Journal of Biological Chemistry|July 13, 2001
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular diseaseS Kantachuvesiri, S Fleming, J Peters, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiovascular Research|June 14, 2002
Application of gene expression profiling to cardiovascular diseaseP A Henriksen, Y Kotelevtsev
Journal of Cardiovascular Pharmacology|November 15, 2000
A transgenic strategy for analysis of the function of the endothelin-B-receptorA Bagnall, D Webb, Y Kotelevtsev
Molecular and Cellular Endocrinology|February 13, 2001
Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genesM C Holmes, Y Kotelevtsev, J J Mullins, et al.
Endocrinology|January 6, 2001
Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient miceH J Harris, Y Kotelevtsev, J J Mullins, et al.
The Journal of Biological Chemistry|September 8, 1995
Human mineralocorticoid receptor genomic structure and identification of expressed isoformsM C Zennaro, M C Keightley, Y Kotelevtsev, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairmentsJ L Yau, J Noble, C J Kenyon, et al.
The Journal of Clinical Investigation|March 13, 1999
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2Y Kotelevtsev, R W Brown, S Fleming, et al.
Kidney International|February 1, 1995
A genetic model of malignant phase hypertension in ratsC E Whitworth, S Fleming, Y Kotelevtsev, et al.
Kidney International|August 5, 1999
Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 ratsS Kantachuvesiri, C S Haley, S Fleming, et al.
The Journal of Biological Chemistry|July 13, 2001
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular diseaseS Kantachuvesiri, S Fleming, J Peters, et al.
Pageof 2